Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01286415 · ClinicalTrials.gov registry record · NA

Group Cognitive Processing Therapy for Combat-related Posttraumatic Stress Disorder (PTSD)

A NA study, sponsored by VA Boston Healthcare System.

Completed
Registry status
NA
Development phase
108
Enrollment target

NCT01286415: Completed NA study, sponsored by VA Boston Healthcare System.

NCT01286415 is a NA study that has completed, run by VA Boston Healthcare System. The registered enrollment target is 108 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01286415, a NA study, has completed, sponsored by VA Boston Healthcare System.

COMPLETED
Registry status
NA
Development phase
108 participants
Enrollment target

Study Summary

The purpose of this study is to compare group-administered Cognitive Processing Therapy-Cognitive-only version (CPT-C), an evidence based treatment for posttraumatic stress disorder (PTSD), to Present Centered Therapy (PCT) in order to determine whether the results of CPT exceed those of receiving a therapy that focuses on current problems rather than past trauma in a group format.

Primary Outcome

PCL-S measures symptoms of posttraumatic stress disorder in response to a specific stressor.

Interventions

  • BEHAVIORAL Group Cognitive Processing Therapy-Cognitive Only
  • BEHAVIORAL Group Present Centered Therapy

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2008-09
Est. Completion 2013-06
Phase NA
VA Boston Healthcare System

17 total trials

What the finished NCT01286415 record still lists

NCT01286415 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 2 interventions - of which Group Cognitive Processing Therapy-Cognitive Only is the first listed.

NCT01286415 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01286415 about?

NCT01286415 is a clinical study titled "Group Cognitive Processing Therapy for Combat-related Posttraumatic Stress Disorder (PTSD)". The purpose of this study is to compare group-administered Cognitive Processing Therapy-Cognitive-only version (CPT-C), an evidence based treatment for posttraumatic stress disorder (PTSD), to Present Centered Therapy (PCT) in order to determine whether the results of CPT exceed those of receiving a...

What is the current status of trial NCT01286415?

This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2008-09. Estimated completion is 2013-06.

What interventions are being tested in trial NCT01286415?

The interventions under investigation include: Group Cognitive Processing Therapy-Cognitive Only (BEHAVIORAL), Group Present Centered Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01286415?

This trial is sponsored by VA Boston Healthcare System, which has 17 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01286415's enrollment target sits among peer trials

108 825th of 2000 higher than 1,171 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01286415, the US trial registry maintained by the National Library of Medicine. NCT01286415 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.